Cargando…

Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF

BACKGROUND: HBV‐related acute‐on‐chronic liver failure (HBV‐ACLF) is the most common type of liver failure with high mortality. Artificial liver support system (ALSS) is an important mean to reduce the mortality of HBV‐ACLF but lacking index to assess its effectiveness. The cytokines are closely rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yandi, Ju, Tao, Zhang, Huafen, Cao, Dan, Li, Xuefen, Yang, Jiezuan, Yan, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756982/ https://www.ncbi.nlm.nih.gov/pubmed/36336888 http://dx.doi.org/10.1002/jcla.24766

Ejemplares similares

Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment
por: Ju, Tao, et al.
Publicado: (2023)

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

A new model for identification of HBV-related pre-ACLF
por: Jalan, Rajiv, et al.
Publicado: (2022)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)
por: Yang, Jiezuan, et al.
Publicado: (2012)

A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients
por: Xia, Qi, et al.
Publicado: (2013)

Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF
por: Wu, Zhe-Bin, et al.
Publicado: (2021)

Mean arterial pressure drop is an independent risk factor of hepatorenal syndrome in patients with HBV-ACLF
por: Zheng, Xingrong, et al.
Publicado: (2022)

Comparing CLIF-C ACLF, CLIF-C ACLF(lactate), and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
por: Kuo, Chao-Cheng, et al.
Publicado: (2021)

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
por: Liu, Fangfang, et al.
Publicado: (2020)

Identification of a Potential miRNA–mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
por: Zhang, Xueyun, et al.
Publicado: (2022)

Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
por: Seeßle, Jessica, et al.
Publicado: (2020)

Serum Lactate Level Predicts Short-Term and Long-Term Mortality of HBV-ACLF Patients: A Prospective Study
por: Nie, Yuan, et al.
Publicado: (2020)

IL28B Is Associated with Outcomes of Chronic HBV Infection
por: Shi, Xiaodong, et al.
Publicado: (2015)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF
por: Li, Ning, et al.
Publicado: (2017)

Characterization of an Artificial Liver Support System-Related Vasovagal Reaction
por: Ma, Shanshan, et al.
Publicado: (2020)

Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure
por: Engelmann, Cornelius, et al.
Publicado: (2018)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
por: Kaps, L., et al.
Publicado: (2021)

Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19
por: Xia, Qi, et al.
Publicado: (2021)

The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2023)

Lower testosterone levels predict increasing severity and worse outcomes of hepatitis B virus-related acute-on-chronic liver failure in males
por: Huang, Yandi, et al.
Publicado: (2021)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV
por: Chen, Jiajia, et al.
Publicado: (2020)

Effect of Artificial Liver Support Systems on Gut Microbiota in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Song, Zhiying, et al.
Publicado: (2023)

Multiple organ involvement and ICU considerations for the care of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in children
por: Mataya, Leslie A., et al.
Publicado: (2021)

Detoxification II Prescription Suppresses the Th-17/IL-17 Inflammatory Axis to Improve the Liver Function of ACLF-Rats via Inactivating the P38MAPK Pathway
por: Shi, Qinglan, et al.
Publicado: (2021)

Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure
por: Ramzan, Moazma, et al.
Publicado: (2020)

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
por: Görgülü, Esra, et al.
Publicado: (2022)

HMGB1-Induced Hepatocyte Pyroptosis Expanding Inflammatory Responses Contributes to the Pathogenesis of Acute-on-Chronic Liver Failure (ACLF)
por: Hou, Weixin, et al.
Publicado: (2021)

The Effect of Artificial Liver Support System on Prognosis of HBV-Derived Hepatorenal Syndrome: A Retrospective Cohort Study
por: Sheng, Xinyu, et al.
Publicado: (2022)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF
por: Premkumar, Madhumita, et al.
Publicado: (2021)

Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients
por: Wang, Fei, et al.
Publicado: (2022)

JNK/c‐Jun pathway activation is essential for HBx‐induced IL‐35 elevation to promote persistent HBV infection
por: Li, Xuefen, et al.
Publicado: (2023)

Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats
por: Fang, Peng, et al.
Publicado: (2021)

Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle
por: Liang, Jiajun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pdis0u1eas0012fvpa2qrenma